Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients

Transplantation

Volumn 97, Issue 8, 2014, Pages 846-853

  Cowan, Michelle ^a   Chon, W James ^a   Desai, Amishi ^a   Andrews, Sarah ^a   Bai, Yaohui ^b,c   Veguilla, Vic ^b   Katz, Jacqueline M ^b   Josephson, Michelle A ^a   Wilson, Patrick C ^a   Sciammas, Roger ^a   Chong, Anita S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

Author keywords

B cells; Immunosuppression; Influenza vaccine; Kidney transplantation; Plasma cells; T cells

Indexed keywords

ADULT; ANTIBODIES, VIRAL; B-LYMPHOCYTES; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA VACCINES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; PROSPECTIVE STUDIES; T-LYMPHOCYTES;

EID: 84899474798     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000438024.10375.2d     Document Type: Article

References (39)

1. Avery RK. Influenza vaccines in the setting of solid-organ transplantation:are they safe? Curr Opin Infect Dis 2012; 25: 464.
2. Danzinger-Isakov L, Kumar D. Guidelines for vaccination of solidorgan transplant candidates and recipients. Am J Transplant 2009;9(Suppl 4): S258.
3. Kumar D, Blumberg EA, Danziger-Isakov L, et al. Influenza vaccinationin the organ transplant recipient: review and summary recommendations.Am J Transplant 2011; 11: 2020.
4. Chon WJ, Kadambi PV, Harland RC, et al. Changing attitudes towardinfluenza vaccination in U.S. Kidney transplant programs over thepast decade. Clin J Am Soc Nephrol 2010; 5: 1637.
5. Perez-Romero P, Aydillo TA, Perez-Ordonez A, et al. Reduced incidenceof pneumonia in influenza-vaccinated solid organ transplantrecipients with influenza disease. Clin Microbiol Infect 2012; 18: E533.
6. Lawal A, Basler C, Branch A, et al. Influenza vaccination in orthotopicliver transplant recipients: absence of post administration ALTelevation.Am J Transplant 2004; 4: 1805.
7. Cordero E, Aydillo TA, Perez-Ordonez A, et al. Deficient long-termresponse to pandemic vaccine results in an insufficient antibody responseto seasonal influenza vaccination in solid organ transplantrecipients. Transplantation 2012; 93: 847.
8. Cordero E, Manuel O. Influenza vaccination in solid-organ transplantrecipients. Curr Opin Organ Transplant 2012; 17: 601.
9. Ott U, Sauerbrei A, Lange J, et al. Serological response to influenza AH1N1 vaccine (Pandemrix(R)) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients. MedMicrobiol Immunol 2012; 201: 297.
10. Crespo M, Collado S, Mir M, et al. Efficacy of influenza A H1N1/2009vaccine in hemodialysis and kidney transplant patients. Clin J Am SocNephrol 2011; 6: 2208.
11. Birdwell KA, Ikizler MR, Sannella EC, et al. Decreased antibodyresponse to influenza vaccination in kidney transplant recipients: aprospective cohort study. Am J Kidney Dis 2009; 54: 112.
12. Blumberg EA, Albano C, Pruett T, et al. The immunogenicity of influenzavirus vaccine in solid organ transplant recipients. Clin InfectDis 1996; 22: 295.
13. Candon S, Thervet E, Lebon P, et al. Humoral and cellular immuneresponses after influenza vaccination in kidney transplant recipients.Am J Transplant 2009; 9: 2346.
14. Schaffer SA, Husain S, Delgado DH, et al. Impact of adjuvanted H1N1vaccine on cell-mediated rejection in heart transplant recipients. Am JTransplant 2011; 11: 2751.
15. Katerinis I, Hadaya K, Duquesnoy R, et al. De novo anti-HLA antibodyafter pandemic H1N1 and seasonal influenza immunization inkidney transplant recipients. Am J Transplant 2011; 11: 1727.
16. Danziger-Isakov L, Cherkassky L, Siegel H, et al. Effects of influenzaimmunization on humoral and cellular alloreactivity in humans.Transplantation 2010; 89: 838.
17. Beyer WE, Palache AM, Luchters G, et al. Seroprotection rate,mean fold increase, seroconversion rate: which parameter adequatelyexpresses seroresponse to influenza vaccination? Virus Res 2004;103: 125.
18. Katz JM, Hancock K, Xu X. Serologic assays for influenza surveillance,diagnosis and vaccine evaluation. Expert Rev Anti Infect Ther2011; 9: 669.
19. Opelz G, Dohler B. Lymphomas after solid organ transplantation: acollaborative transplant study report. Am J Transplant 2004; 4: 222.
20. Bhorade SM, Stern E. Immunosuppression for lung transplantation.Proc Am Thorac Soc 2009; 6: 47.
21. Samaniego M, Becker BN, Djamali A. Drug insight: maintenanceimmunosuppression in kidney transplant recipients. Nat Clin PractNephrol 2006; 2: 688.
22. Eckerle I, Rosenberger KD, Zwahlen M, et al. Serologic vaccinationresponse after solid organ transplantation: a systematic review. PloSOne 2013; 8: e56974.
23. Li GM, Chiu C, Wrammert J, et al. Pandemic H1N1 influenza vaccineinduces a recall response in humans that favors broadly cross-reactivememory B cells. Proc Natl Acad Sci USA 2012; 109: 9047.
24. Wrammert J, Smith K, Miller J, et al. Rapid cloning of high-affinityhuman monoclonal antibodies against influenza virus. Nature 2008;453: 667.
25. Sasaki S, Sullivan M, Narvaez CF, et al. Limited efficacy of inactivatedinfluenza vaccine in elderly individuals is associated with decreasedproduction of vaccine-specific antibodies. J Clin Invest 2011;121: 3109.
26. Wrammert J, Koutsonanos D, Li GM, et al. Broadly cross-reactiveantibodies dominate the human B cell response against 2009 pandemicH1N1 influenza virus infection. J Exp Med 2011; 208: 181.
27. Srinivas TR, Kaplan B, Meier-Kriesche HU. Mycophenolate mofetil insolid-organ transplantation. Expert Opin Pharmacother 2003; 4: 2325.
28. Bot A, Bot S, Bona CA. Protective role of gamma interferon during therecall response to influenza virus. J Virol 1998; 72: 6637.
29. Bot A, Bot S, Garcia-Sastre A, et al. Protective cellular immunityagainst influenza virus induced by plasmid inoculation of newbornmice. Dev Immunol 1998; 5: 197.
30. Forrest BD, Pride MW, Dunning AJ, et al. Correlation of cellularimmune responses with protection against culture-confirmed influenzavirus in young children. Clin Vaccine Immunol 2008; 15: 1042.
31. Avetisyan G, Ragnavolgyi E, Toth GT, et al. Cell-mediated immuneresponses to influenza vaccination in healthy volunteers and allogeneicstem cell transplant recipients. Bone Marrow Transplant 2005;36: 411.
32. Deng Y, Jing Y, Campbell AE, et al. Age-related impaired type 1 T cellresponses to influenza: reduced activation ex vivo, decreased expansionin CTL culture in vitro, and blunted response to influenza vaccinationin vivo in the elderly. J Immunol 2004; 172: 3437.
33. Faenzi E, Zedda L, Bardelli M, et al. One dose of an MF59- adjuvantedpandemic A/H1N1 vaccine recruits pre-existing immune memoryand induces the rapid rise of neutralizing antibodies. Vaccine 2012;30: 4086.
34. Tsuda K, Yamanaka K, Kitagawa H, et al. Calcineurin inhibitorssuppress cytokine production from memory T cells and differentiationof naive T cells into cytokine-producing mature T cells. PloS One2012; 7: e31465.
35. Pearl JP, Parris J, Hale DA, et al. Immunocompetent T-cells with amemory-like phenotype are the dominant cell type followingantibody-mediated T-cell depletion. Am J Transplant 2005; 5: 465.
36. Nakaya HI, Li S, Pulendran B. Systems vaccinology: learning tocompute the behavior of vaccine induced immunity. Wiley InterdiscipRev Syst Biol Med 2012; 4: 193.
37. Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations:a review of infection frequency, morbidity, mortality, and vaccine responses.Lancet Infect Dis 2009; 9: 493.
38. Kendal AP, Pereira MS, Skehel JJ. Concepts and Procedures forLaboratory-Based Influenza Surveillance. Atlanta, GA: U. S. Departmentof Health and Human Services, Public Health Service, Centersfor Disease Control; 1982.
39. Rowe T, Abernathy RA, Hu-Primmer J, et al. Detection of antibody toavian influenza A (H5N1) virus in human serum by using a combinationof serologic assays. J Clin Microbiol 1999; 37: 937.